These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 33971448)
1. Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study. Glosli H; Bisogno G; Kelsey A; Chisholm JC; Gaze M; Kolb F; McHugh K; Shipley J; Gallego S; Merks JHM; Smeele LE; Mandeville H; Ferrari A; Minard-Colin V; Corradini N; Jenney M; Zanetti I; De Salvo GL; Orbach D; Eur J Cancer; 2021 Jul; 151():84-93. PubMed ID: 33971448 [TBL] [Abstract][Full Text] [Related]
2. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study. Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071 [TBL] [Abstract][Full Text] [Related]
3. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children]. Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063 [No Abstract] [Full Text] [Related]
4. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report. Mercolini F; Merks JHM; Minard-Colin V; Cameron A; van Scheltinga SEJT; Sher O; Fichera G; Orbach D; Glosli H; Coppadoro B; Gallego S; Chisholm JC; Bisogno G Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598 [TBL] [Abstract][Full Text] [Related]
5. Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study. Terwisscha van Scheltinga SEJ; Wijnen MHWA; Martelli H; Rogers T; Mandeville H; Gaze MN; McHugh K; Corradini N; Orbach D; Jenney M; Kelsey A; Chisholm J; Gallego S; Glosli H; Ferrari A; Zanetti I; De Salvo GL; Minard-Colin V; Bisogno G; van Noesel MM; Merks HHM Cancer Med; 2020 Oct; 9(20):7580-7589. PubMed ID: 32869534 [TBL] [Abstract][Full Text] [Related]
6. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Gallego S; Zanetti I; Orbach D; Ranchère D; Shipley J; Zin A; Bergeron C; de Salvo GL; Chisholm J; Ferrari A; Jenney M; Mandeville HC; Rogers T; Merks JHM; Mudry P; Glosli H; Milano GM; Ferman S; Bisogno G; Cancer; 2018 Aug; 124(15):3201-3209. PubMed ID: 29797665 [TBL] [Abstract][Full Text] [Related]
7. Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma-The French Experience. Machavoine R; Helfre S; Bernier V; Bolle S; Leseur J; Corradini N; Rome A; Defachelles AS; Deneuve S; Bernard S; Fayoux P; Nicollas R; Mondain M; Luscan R; Denoyelle F; Simon F; Kadlub N; Kolb F; Honart JF; Orbach D; Minard-Colin V; Moya-Plana A; Couloigner V Front Pediatr; 2021; 9():783754. PubMed ID: 35186818 [TBL] [Abstract][Full Text] [Related]
8. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. Bisogno G; De Salvo GL; Bergeron C; Gallego Melcón S; Merks JH; Kelsey A; Martelli H; Minard-Colin V; Orbach D; Glosli H; Chisholm J; Casanova M; Zanetti I; Devalck C; Ben-Arush M; Mudry P; Ferman S; Jenney M; Ferrari A; Lancet Oncol; 2019 Nov; 20(11):1566-1575. PubMed ID: 31562043 [TBL] [Abstract][Full Text] [Related]
9. Paratesticular rhabdomyosarcoma-Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG). Rogers TN; De Corti F; Burrieza GG; Guérin F; Terwisscha van Scheltinga S; Smeulders N; Craigie R; Jenney M; Kelsey A; Zanetti I; Coppadoro B; De Salvo GL; Bisogno G; Martelli H Pediatr Blood Cancer; 2020 Sep; 67(9):e28479. PubMed ID: 32573979 [TBL] [Abstract][Full Text] [Related]
10. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee. Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716 [TBL] [Abstract][Full Text] [Related]
11. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group. Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W; Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224 [TBL] [Abstract][Full Text] [Related]
12. Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups. Gallego S; Chi YY; De Salvo GL; Li M; Merks JHM; Rodeberg DA; van Scheltinga ST; Mascarenhas L; Orbach D; Jenney M; Million L; Minard-Colin V; Wolden S; Zanetti I; Parham DM; Mandeville H; Venkatramani R; Bisogno G; Hawkins DS; Pediatr Blood Cancer; 2021 Mar; 68(3):e28832. PubMed ID: 33245207 [TBL] [Abstract][Full Text] [Related]
13. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG). Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481 [TBL] [Abstract][Full Text] [Related]
14. Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups. Minard-Colin V; Walterhouse D; Bisogno G; Martelli H; Anderson J; Rodeberg DA; Ferrari A; Jenney M; Wolden S; De Salvo G; Arndt C; Merks JHM; Gallego S; Schwob D; Haie-Meder C; Bergeron C; Stevens MCG; Oberlin O; Hawkins D; Pediatr Blood Cancer; 2018 Sep; 65(9):e27096. PubMed ID: 29781567 [TBL] [Abstract][Full Text] [Related]
15. Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies. Rogers T; Zanetti I; Coppadoro B; Martelli H; Jenney M; Minard-Colin V; Terwisscha van Scheltinga SEJ; Skerritt C; Fajardo RD; Guérin F; Kelsey A; Merks JHM; Mandeville H; Guillén G; Glosli H; De Corti F; Bisogno G Pediatr Blood Cancer; 2022 Sep; 69(9):e29739. PubMed ID: 35460336 [TBL] [Abstract][Full Text] [Related]
16. Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience. Bergeron C; Jenney M; De Corti F; Gallego S; Merks H; Glosli H; Ferrari A; Ranchère-Vince D; De Salvo GL; Zanetti I; Chisholm J; Minard-Colin V; Rogers T; Bisogno G; Eur J Cancer; 2021 Mar; 146():21-29. PubMed ID: 33567392 [TBL] [Abstract][Full Text] [Related]
17. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005. Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136 [TBL] [Abstract][Full Text] [Related]
18. Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group. Ben-Arush M; Minard-Colin V; Scarzello G; Fajardo RD; Terwisscha Van Scheltinga S; Bernier V; Jenney M; Gallego S; Zanetti I; Cesen M; Merks JHM; Bisogno G Eur J Cancer; 2022 Sep; 172():119-129. PubMed ID: 35763871 [TBL] [Abstract][Full Text] [Related]
19. Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram. De Salvo GL; Del Bianco P; Minard-Colin V; Chisholm J; Jenney M; Guillen G; Devalck C; Van Rijn R; Shipley J; Orbach D; Kelsey A; Rogers T; Guerin F; Scarzello G; Ferrari A; Cesen Mazic M; Merks JHM; Bisogno G; Cancer; 2024 Jul; 130(13):2351-2360. PubMed ID: 38400828 [TBL] [Abstract][Full Text] [Related]
20. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M; Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]